ANI Pharmaceuticals | ANIP - Operating Profit


ANI Pharmaceuticals reported $39.84M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
ANI Pharmaceuticals USD 39.84M 1.13M Jun/2026
Aurora Cannabis CAD -10.03M 25.76M Mar/2026
Canopy Growth CAD -27.47M 14.81M Mar/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
Emergent BioSolutions USD -218M 69.9M Jun/2023
Heron Therapeutics USD 38K 3.83M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Novartis USD 4.24B 171M Mar/2026
Omeros USD -35.41M 23.75M Sep/2024
Perrigo USD 23.5M 10.1M Jun/2026
Sun Pharmaceuticals INR 35.57B 8.05B Jun/2026
Teva Pharmaceutical Industries USD 235M 523M Jun/2026